Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

AMP 2022

Quality of Life Improvement After PVI, Long-Term Safety for Atherectomy Devices, and More

Eric Secemsky, MD 

Beth Israel Deaconess Medical Center, Boston, Massachusetts

10/15/2022

 

In this video, Dr. Eric Secemsky discusses several of his presentations at AMP 2022, including Quality of Life Improvement After PVI,  Long-Term Safety for Atherectomy Devices, and more. 


Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest
Peripheral Intervention
FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature
07/16/2024
“The XO technology has shown effectiveness modifying, cracking, and dilating intimal and medial calcium using low pressures,” said Richard Saxon, MD, FSIR of Tri-City Medical, San Diego, California.
“The XO technology has shown effectiveness modifying, cracking, and dilating intimal and medial calcium using low pressures,” said Richard Saxon, MD, FSIR of Tri-City Medical, San Diego, California.
“The XO technology has shown...
07/16/2024
Cath Lab Digest
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Vascular Closure
Cordis Receives FDA Approval for MYNX CONTROL VENOUS Vascular Closure Device
07/09/2024
Leveraging GRIP TECHNOLOGY™, based on hydrophilic, bioinert polyethylene glycol (PEG), the MYNX CONTROL™ VENOUS VCD sealant resorbs 3x faster than collagen-based sealants and provides the quickest time to hemostasis of any venous closure...
Leveraging GRIP TECHNOLOGY™, based on hydrophilic, bioinert polyethylene glycol (PEG), the MYNX CONTROL™ VENOUS VCD sealant resorbs 3x faster than collagen-based sealants and provides the quickest time to hemostasis of any venous closure...
Leveraging GRIP TECHNOLOGY™,...
07/09/2024
Cath Lab Digest
Coronary In-stent Restenosis
CIS is First in the Capital Region to Use the AGENT™ Drug-Coated Balloon to Treat Coronary In-Stent Restenosis
07/03/2024
ZACHARY, LA – Dr. Abdullah Munir, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in the Capital Region and second in Louisiana to use the AGENT™ Drug-Coated Balloon, the first FDA-approved drug-coated...
ZACHARY, LA – Dr. Abdullah Munir, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in the Capital Region and second in Louisiana to use the AGENT™ Drug-Coated Balloon, the first FDA-approved drug-coated...
ZACHARY, LA – Dr. Abdullah...
07/03/2024
Vascular Disease Management
thoracic endovascular aortic repair
First Commercial Implant of the GORE® TAG® Thoracic Branch Endoprosthesis in Canada
06/28/2024
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible,...
06/28/2024
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement